Multaq and Bisacodyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Multaq (dronedarone hydrochloride) and Bisacodyl (bisacodyl). Common drug interactions include dyspnoea among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Multaq and Bisacodyl. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Multaq?

Multaq has active ingredients of dronedarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 11,053 Multaq users. Check the latest studies of Multaq.

What is Bisacodyl?

Bisacodyl has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 18,852 Bisacodyl users. Check the latest studies of Bisacodyl.



On Jul, 09, 2026

18 people who take Multaq and Bisacodyl together, and have interactions are studied.

Multaq and Bisacodyl drug interactions.

What are the common drug interactions of Multaq and Bisacodyl, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Hereditary angioedema (recurrent episodes of severe swelling)
  3. Lung disorder (lung disease)
  4. Pleural effusion (water on the lungs)
  5. Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
  6. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  7. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  8. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  9. Brain natriuretic peptide increased
  10. Cardiac arrest

male:

  1. Cardiac failure congestive
  2. Hypoglycaemia (deficiency of glucose in the bloodstream)
  3. Perineal abscess
  4. Pneumonia
  5. Renal failure (kidney dysfunction)
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Scrotal abscess (pus in scrotum)
  8. Wound infection
  9. Abdominal distension
  10. Anxiety

What are the common drug interactions of Multaq and Bisacodyl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cardiac failure congestive
  2. Abdominal distension
  3. Actinic keratosis (skin disease due to sun exposure)
  4. Anxiety
  5. Arteriosclerosis (thickening and hardening of arteries)
  6. Asthenia (weakness)
  7. Atrioventricular dissociation (av block)
  8. Balance disorder
  9. Blood pressure decreased
  10. Bronchial hyperreactivity

50-59:

  1. Actinic keratosis (skin disease due to sun exposure)
  2. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  3. Cardiac failure congestive
  4. Chapped lips (cracking, fissuring, and peeling of the skin f lip)
  5. Chronic kidney disease
  6. Colon cancer
  7. Gangrene (body tissue dies)
  8. Hypertension (high blood pressure)
  9. Hypoglycaemia (deficiency of glucose in the bloodstream)
  10. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Hereditary angioedema (recurrent episodes of severe swelling)
  3. Brain natriuretic peptide increased
  4. Cardiac failure congestive
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Colitis (inflammation of colon)
  7. Fatigue (feeling of tiredness)
  8. Haemoglobin decreased
  9. Hyperkalaemia (damage to or disease of the kidney)
  10. Hypoglycaemia (deficiency of glucose in the bloodstream)

What are the existing conditions these people have? *

  1. Hereditary Angioedema (recurrent episodes of severe swelling): 3 people, 16.67%
  2. Pain: 3 people, 16.67%
  3. Immune System Disorder: 3 people, 16.67%
  4. Type 2 Diabetes: 2 people, 11.11%
  5. Hypotension (abnormally low blood pressure): 2 people, 11.11%
  6. Weight Decreased: 2 people, 11.11%
  7. Colitis (inflammation of colon): 1 person, 5.56%
  8. Cough: 1 person, 5.56%
  9. Heart Attack: 1 person, 5.56%
  10. Dizziness: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Multaq and Bisacodyl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Multaq and Bisacodyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Multaq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bisacodyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Multaq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bisacodyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dronedarone hydrochloride and bisacodyl (the active ingredients of Multaq and Bisacodyl, respectively), and Multaq and Bisacodyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: